Zusammenfassung
Das perioperative Risiko einer unerwünschten kardialen Komplikation hängt im Wesentlichen von der präoperativen Konstitution des Patienten, dessen Begleiterkrankungen und der Größe bzw. Länge der geplanten Operation ab.
Um das perioperative kardiale Risiko besser einschätzen zu können und um die perioperative Behandlungsmöglichkeiten und das postoperative Ergebnis zu verbessern, hat die europäische Gesellschaft für Kardiologie in Zusammenarbeit mit der europäischen Gesellschaft für Anästhesiologie im Jahr 2009 neue Leitlinien verfasst. Diese Leitlinien setzen zwei Schwerpunkte: die präoperative Risikoeinschätzung, abgeleitet aus den Begleiterkrankungen des Patienten und aus der Schwere bzw. Länge des geplanten chirurgischen Eingriffes, sowie das perioperative Management in Abhängigkeit von der zuvor festgelegten Risikoeinschätzung.
In Anlehnung an diese Leitlinien gibt dieser Artikel einen kurzen Überblick zu dem Thema, wobei sich insbesondere auf die vorbestehenden kardialen Begleiterkrankungen und das perioperative kardiale Management konzentriert wird.
Abstract
The perioperative risk of a cardiac complication is primarily determined by the patient’s preoperative constitution, any existing comorbidities as well as the extent and the duration of the intended surgery. Consequently, the European Society of Cardiology (ESC) endorsed by the European Society of Anaesthesiology (ESA) published guidelines in 2009 aiming at improving perioperative cardiac risk assessment and perioperative treatment as well as the postoperative outcome. In line with these objectives the guidelines mainly focus on two areas: the preoperative risk assessment based on the patients’ comorbidities and the anticipated severity of the intended surgery itself and secondly on the perioperative management derived from the outcome of the previous risk assessment. On the basis of these guidelines this article gives a brief overview on the subject focusing on existing cardiac comorbidities and perioperative cardiac management.
Abbreviations
- MET:
-
Metabolic equivalent
- TIA:
-
Transistorisch Ischämische Attacke
- AICD:
-
Automatic implantable cardioverter defibrillator
- LV- Funktion:
-
Linksventrikuläre Funktion
- NSTEMI:
-
Nicht ST-Strecken Hebungsinfarkt
- BMS:
-
Bare metal Stent
- DES:
-
Drug-eluting Stent
- PCI:
-
Perkutane koronar Intervention
- PTCA:
-
Perkutane transluminale Ballonangioplastie
Literatur
Almanaseer Y, Mukherjee D, Kline-Rogers EM et al (2005) Implementation of the ACC/AHA guidelines for preoperative cardiac risk assessment in a general medicine preoperative clinic: improving efficiency and preserving outcomes. Cardiology 103:24–29
Biondi-Zoccai GG, Lotrionte M, Agostoni P et al (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27:2667–2674
Boersma E, Kertai MD, Schouten O et al (2005) Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118:1134–1141
Brady AR, Gibbs JS, Greenhalgh RM et al (2005) Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41:602–609
Burger W, Chemnitius JM, Kneissl GD et al (2005) Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med 257:399–414
Devereaux PJ, Yang H, Yusuf S et al (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371:1839–1847
Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442
Dunkelgrun M, Boersma E, Schouten O et al (2009) Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 249:921–926
Elhendy A, Valkema R, Van Domburg RT et al (1998) Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med 39:1662–1666
Ferguson TB Jr, Hammill BG, Peterson ED et al (2002) A decade of change – risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 73:480–489; discussion 489–490
Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J 27:1341–1381
Graham I, Atar D, Borch-Johnsen K et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary: fourth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 28:2375–2414
Howard-Alpe GM, De Bono J, Hudsmith L et al (2007) Coronary artery stents and non-cardiac surgery. Br J Anaesth 98:560–574
Huber KC, Evans MA, Bresnahan JF et al (1992) Outcome of noncardiac operations in patients with severe coronary artery disease successfully treated preoperatively with coronary angioplasty. Mayo Clinic proceedings. Mayo Clinic 67:15–21
Juul AB, Wetterslev J, Gluud C et al (2006) Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ (Clinical research ed.) 332:1482
Kaluza GL, Joseph J, Lee JR et al (2000) Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35:1288–1294
Kelm M, Osterhues H, Hennerici MG et al (2010) Kommentar zu den ESC Guidelines for Pre-Operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery. Der Kardiologe 5:375–382
Kertai MD, Boersma E, Bax JJ et al (2003) A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart (British Cardiac Society) 89:1327–1334
Lee TH, Marcantonio ER, Mangione CM et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049
Mangano DT (2004) Perioperative medicine: NHLBI working group deliberations and recommendations. J Cardiothorac Vasc Anesth 18:1–6
Mangano DT, Goldman L (1995) Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 333:1750–1756
Mangano DT, Layug EL, Wallace A et al (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713–1720
Morris CK, Ueshima K, Kawaguchi T et al (1991) The prognostic value of exercise capacity: a review of the literature. Am Heart J 122:1423–1431
Naughton C, Feneck RO (2007) The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective non-cardiac surgery. Int J Clin Pract 61:768–776
Nuttall GA, Brown MJ, Stombaugh JW et al (2008) Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 109:588–595
Oosterga M, Voors AA, Pinto YM et al (2001) Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol 87:542–546
Poldermans D, Bax JJ, Boersma E et al (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 30:2769–2812
Poldermans D, Bax JJ, Kertai MD et al (2003) Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107:1848–1851
Poldermans D, Bax JJ, Schouten O et al (2006) Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 48:964–969
Poldermans D, Boersma E, Bax JJ et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789–1794
Rosenson RS, Tangney CC (1998) Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 279:1643–1650
Schiefermueller J, Myerson S, Handa AI (2012) Preoperative assessment and perioperative management of cardiovascular risk. Angiology. Epub ahead of print
Sicari R, Nihoyannopoulos P, Evangelista A et al (2009) Stress echocardiography expert consensus statement-executive summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 30:278–289
Sun YP, Zhu BQ, Browne AE et al (2001) Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function. J Cardiovasc Pharmacol Ther 6:175–181
Wiklund RA, Stein HD, Rosenbaum SH (2001) Activities of daily living and cardiovascular complications following elective, noncardiac surgery. YJBM 74:75–87
Yang H, Raymer K, Butler R et al (2006) The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152:983–990
Zaugg M, Bestmann L, Wacker J et al (2007) Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 107:33–44
Interessenkonflikt
Die korrespondierende Autorin gibt für sich und ihre Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Markworth, F., Debus, E. & Blankenberg, S. Elektive nicht kardiochirurgische Operationen bei Patienten mit kardialer Grunderkrankung. Gefässchirurgie 18, 21–27 (2013). https://doi.org/10.1007/s00772-012-1108-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00772-012-1108-2
Schlüsselwörter
- Perioperatives Risiko
- Präoperative Risikoeinschätzung
- Kardiale Risikofaktoren
- Nicht kardiochirurgische Operationen
- Perioperative Behandlung